Course Content
Endocrine & Reproductive System Module — 4th Year MBBS
AIM Concept Integration
4th Year MBBS
Endocrine + Reproduction

Parathyroid Disorders: Hyperparathyroidism and Hypoparathyroidism

Connect PTH disturbance with calcium–phosphate changes, clinical manifestations, diagnostic patterns and the main treatment principles for rapid KMU-oriented revision.

:contentReference[oaicite:0]{index=0}

1. THE TOPIC IN ONE CONNECTED FLOW

Parathyroid disorders are best understood by following what happens to PTH and then predicting the calcium and phosphate response. Excess PTH mainly produces hypercalcemic complications, while deficient PTH produces hypocalcemia with increased neuromuscular excitability. The biochemical pattern then guides diagnosis and treatment.

Hyperparathyroidism pathway
Cause
Adenoma / hyperplasia
or chronic stimulation
PTH excess
Primary, secondary or tertiary
Bone + kidney effects
Bone resorption ↑
Phosphate excretion ↑
Functional change
Calcium tends to rise
Phosphate falls in primary disease
Clinical effects
Renal stones, bone disease, weakness, polyuria
Diagnosis
Interpret calcium together with PTH
Treatment
Treat hypercalcemia + correct the source of PTH excess
Hypoparathyroidism pathway
Cause
Postsurgical damage, autoimmune or congenital loss
PTH deficiency
Reduced parathyroid function
Renal + vitamin D effects
Calcium conservation ↓
Phosphate excretion ↓
Biochemical change
Calcium ↓
Phosphate ↑
Clinical effects
Paresthesia, cramps, tetany, seizures
Diagnosis
Low calcium + high phosphate + low/inappropriate PTH
Treatment
Calcium + active vitamin D; urgent IV calcium if severe

2. KEY CLINICAL CONNECTIONS

Calcium + PTH Interpretation
Hypercalcemia
→ PTH should normally be suppressed
→ elevated or inappropriately non-suppressed PTH
PTH-dependent hypercalcemia.
Hypocalcemia
→ PTH should rise
→ low or inappropriately normal PTH
parathyroid failure.
PTH Excess → Bone and Kidney Disease
Sustained PTH excess
→ increased bone resorption
→ weakened bone
osteitis fibrosa cystica / brown tumors.
Hypercalcemia + increased urinary calcium
→ renal calcium deposition
calculi or nephrocalcinosis.
Treatment Follows the Mechanism
Primary hyperparathyroidism
→ abnormal gland
→ definitive therapy is parathyroidectomy when indicated.
Hypoparathyroidism
→ absent PTH effect
→ calcium + active vitamin D
→ restore calcium while avoiding excessive urinary calcium.

3. AIM HIGH-YIELD INTEGRATION REVIEW

Primary hyperparathyroidism: intrinsic gland abnormality → PTH escapes normal calcium feedback → hypercalcemia.
Secondary hyperparathyroidism: persistent hypocalcemic stimulus → compensatory PTH rise → multigland hyperplasia.
Tertiary hyperparathyroidism: prolonged secondary stimulation → autonomous glands → high PTH with hypercalcemia.
CKD: phosphate retention + reduced active vitamin D → lower calcium stimulus → secondary PTH elevation.
PTH excess: increased bone turnover → skeletal weakening; hypercalcemia → polyuria, dehydration and renal complications.
Hypoparathyroidism: low PTH → low calcium + high phosphate → increased neuromuscular excitability and tetany.
Severe hypocalcemia: tetany, seizures, laryngospasm or cardiac effects → urgent intravenous calcium with monitoring.
Chronic hypoparathyroidism: calcium + active vitamin D → symptom control, but excessive replacement can cause hypercalciuria and renal damage.
AIM Exam Trap: Biochemistry establishes hyperparathyroidism. Parathyroid ultrasound or radionuclide imaging → localizes the abnormal gland before surgery; it does not establish the diagnosis.
Scroll to Top
💬 WhatsApp Support